14C-urea breath test in patients undergoing anti-tuberculosis therapy

Table 1 Patient characteristics.

Gender	Male	23 (65.7%)
	Female	12 (34.3%)
	Total	35
Age (yr)	Male	17-55 (38.5±11.2)
	Female	16-39 (24.0±8.6)
Type of infection	Pulmonary TB	12
	TB adenitis	9
	TB enteritis	5
	TB osteomyelitis (vertebra)	5
	Meningeal TB	2
	Peritoneal TB	2
	Total	35

Table 2 ¹⁴C-urea breath test results among 35 patients during the course of anti-tuberculosis therapy.

	Baseline	End of 2nd mo of therapy	End of treatment course	One month after completion on therapy
Positive (%)	35 (100)	0 (0)	4(11.4)	22 (62.9)
Negative (%)	0 (0)	35 (100)	30 (85.7)	13(37.1)